SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-20-000552
Filing Date
2020-04-21
Accepted
2020-04-21 16:17:49
Documents
15
Period of Report
2020-04-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 USANA HEALTH SCIENCES, INC. 8-K a52207316.htm   iXBRL 8-K 30960
2 EXHIBIT 99.1 a52207316ex99_1.htm EX-99.1 164488
3 EXHIBIT 99.2 a52207316ex99_2.htm EX-99.2 64627
7 LOGO commentary_logo.jpg GRAPHIC 9438
  Complete submission text file 0001157523-20-000552.txt   440923

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA usna-20200421.xsd EX-101.SCH 4186
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE usna-20200421_lab.xml EX-101.LAB 23692
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE usna-20200421_pre.xml EX-101.PRE 16824
14 EXTRACTED XBRL INSTANCE DOCUMENT a52207316_htm.xml XML 4086
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

IRS No.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1228
Type: 8-K | Act: 34 | File No.: 001-35024 | Film No.: 20805351
SIC: 2833 Medicinal Chemicals & Botanical Products